Dr. Harsha Rajasimha, Founder and CEO of Jeeva Informatics, highlights the importance and value of Investigator-Initiated Trials (IITs) in gathering real-world data on the efficacy, alternate uses, treatment comparisons, and cost-effectiveness of licensed drugs. Led by
The Inflation Reduction Act of 2022 (IRA) covers new and reinstated tax laws that will affect individuals and businesses. Through IRA, President Joe Biden delivered on his promise to lower prescription drug costs by allowing, for
Drug pricing controls imposed by the Inflation Reduction Act of 2022 may appear positive for patients in the short term. However, these controls may have unintended consequences on biopharmaceutical drug development programs and investments in the
CCF grants support startups, critical early technology testing and market validation efforts. RICHMOND, VIRGINIA, UNITED STATES, June 27, 2023/EINPresswire.com/ — The Virginia Innovation Partnership Corporation (VIPC) today announced that Jeeva Informatics Solutions Inc. has been awarded
The FDA has released new guidance for decentralized clinical trials (DCTs) for drugs, biological products, and medical devices to improve DCT implementation. Dr. Harsha Rajasimha, Founder and CEO of Jeeva Informatics, has been a vocal proponent
Genomics expert and social entrepreneur, Harsha Rajasimha, looks to bridge OMICS and Exposure Health with partner DailyBreath at the inaugural total exposure health conference this week. Bethesda, MD – Jeeva Informatics Solutions (Jeeva), a premier healthcare
The value of life-saving drugs for patients suffering from serious diseases is priceless. But the current economic environment is stifling the biopharmaceutical pipeline of up-and-coming clinical trials. Dr. Harsha Rajasimha, Founder and CEO of Jeeva Informatics
Clinical trials are the long and complex process by which biopharmaceutical companies must prove the safety and efficacy of investigational new therapies to FDA before they can be considered for marketing approvals. The process usually takes
Between logistical burdens, distrust in the healthcare system, and lack of awareness and information in many non-English languages, key demographic groups like women, children, low-income households, and racial and ethnic minorities are effectively left out of
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here. NOTE TO REPORTERS AND EDITORS: Members of the media and public are invited to a webinar on Tuesday, December 13 at 1:00 p.m.
